Haemonetics to Participate in 2017 BTIG Conference

[back to news]

Haemonetics Corporation (NYSE: HAE)’s CFO, Bill Burke, and VP-Investor Relations, Gerry Gould, will participate in BTIG’s 2017 Medical Technology, Life Science and Diagnostic Tools Conference on March 1-2, 2017 in Snowbird, Utah. BTIG’s annual conference brings together over 70 leading healthcare companies with institutional investors. 

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Haemonetics’ technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com

Investor Contact: 
Gerry Gould, VP-Investor Relations